USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
U.S. Pharmacogenomics Markets
06-Jun-2001
North America
Market Research
7965-01-00-00-00
HC00378-NA-MR_03582
The U.S. Pharmacogenomics Market report focuses on the varying dynamics of the pharmacogenomics market. This report covers the Pharmacogenomics services, Gene-based Diagnostics, and Orphan Drugs segments. This report provides an in-depth analysis of the revenue sales forecasts for the market, drivers and restraints that affect the current and future markets, industry challenges and strategies, competitive, pricing and demand analysis and market and technology trends. The base year for this report is 2000.
Market Overview
- Pharmacogenomics and Polymorphisms
- The Advantages of Pharmacogenomics
- Market for Pharmacogenomics
Analysis by Major Segments
- Overview
- Service Market of Pharmacogenomics
- Diagnostics
- Orphan Drugs
- Overall Trends
- Competitive Analysis
- Technologies
Research and Scope
Methodology and Definitions
- Objectives and Validation
- Structure and Segmentation
- Forecast Period - Milestones
Total Market Analysis
- Research Methodology
- List of Definitions
- List of Acronyms
Conclusion
- Market Overview
- Market Challenges
- Market Drivers
- Market Restraints
- Market Forecast
Market Engineering Awards
- Recommendations
- Concluding Remarks
Service Market
Microarrays Market
Bioinformatics Market
Present Status of Diagnostics in Pharmacogenomics
Future Status for Diagnostics in Pharmacogenomics
Background
The Present Market for Orphan Drugs
The Future for Orphan Drugs
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
08 Oct 2026 | Global | Frost Radar
Frost Radar: Endoscopy Device Technology Ecosystem, 2026
The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...
07 Oct 2026 | Global | Technology Research
Growth Opportunities in Image-Guided Cancer Ablation Systems
Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.